AI-Powered Pharmaceutical
Portfolio Management (PPMAI)

Improve drug development.

Provide actionable insights.

Increase commercial and therapeutic value.

Get

The right drug

To the right patient

At the right time.

What we do

our solutions

How we can help you

Clinical Research
DDRNAi
See our solutions
Pharmaceutical Portfolio Management
PPMAi
See our solutions

in the media

News and Development

15 AI Companies in Quebec, Canada that you need to know about

Startupbubble

Read the article

CQDM and Sorintellis Group fund the development of an AI-powered platform to mitigate clinical trial risks

CQDM

Read the article

Sorintellis, IVADO, Polytechnique Montréal and Université de Montréal join forces to transform pharmaceutical portfolio management through AI with support from MITACS

Mitacs

Read the article

Interview with Emmanuel Piffo, Sorintellis’ CEO

Prompt

Read the article

Decision-making system for strategic pharmaceutical portfolio management based on artificial intelligence

Mitacs

Read the article

Sorintellis, in partnership with Vantage BioTrials, completes the development of the proof-of-concept for an a priori estimation of the evolution of clinical trial success based on machine learning.

Vantage Biotrials

Read the article

Sorintellis, in collaboration with the multinational pharmaceutical Pfizer, is advancing its ambition to develop an AI-based platform aimed at efficiently mitigating risks in clinical drug development

Pfizer

Read the article

our partners

Partnerships and collaborations

Need more information?

Contact us